Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015–18: a matched cohort study and self-controlled case series-Reference-Cited by-同舟云学术

Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015–18: a matched cohort study and self-controlled case series

Published:2024-05 Issue:5 Volume:24 Page:504-513
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Cerqueira-Silva Thiago,Pescarini Julia M,Cardim Luciana L,Leyrat Clémence,Whitaker Heather,Antunes de Brito Carlos Alexandre,Brickley Elizabeth B,Barral-Netto Manoel,Barreto Maurício L,Teixeira Maria G,Boaventura Viviane S,Paixão Enny S

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado da Bahia

Wellcome Trust

Medical Research Council

Publisher

Elsevier BV

Reference30 articles.

1. An evaluation of global chikungunya clinical management guidelines: a systematic review;Webb;eClinicalMedicine,2022

3. Current strategies for inhibition of chikungunya infection;Subudhi;Viruses,2018

4. Medical consequences of persistent viral infection;Southern;N Engl J Med,1986

5. Major acute cardiovascular events after dengue infection—a population-based observational study;Wei;PLoS Negl Trop Dis,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents;The Lancet Infectious Diseases;2024-09

2. Central and Peripheral Nervous System Manifestations Associated with Dengue Illness;Viruses;2024-08-28

3. Chikungunya vaccine VLA1553 induces sustained protective antibody concentrations;The Lancet Infectious Diseases;2024-08

4. The deadly potential of chikungunya virus;The Lancet Infectious Diseases;2024-05

5. Identification of the Hub Genes Involved in Chikungunya Viral Infection;Cureus;2024-04-04